175 related articles for article (PubMed ID: 33316404)
21. Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation.
Xu X; Ren J; Ma Y; Liu H; Rong Q; Feng Y; Wang Y; Cheng Y; Ge R; Li Z; Bian J
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):250-263. PubMed ID: 30734612
[TBL] [Abstract][Full Text] [Related]
22. Discovery of IDO1 and DNA dual targeting antitumor agents.
Fang K; Wu S; Dong G; Wu Y; Chen S; Liu J; Wang W; Sheng C
Org Biomol Chem; 2017 Dec; 15(47):9992-9995. PubMed ID: 29177308
[TBL] [Abstract][Full Text] [Related]
23. The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.
Fallarini S; Bhela IP; Aprile S; Torre E; Ranza A; Orecchini E; Panfili E; Pallotta MT; Massarotti A; Serafini M; Pirali T
ChemMedChem; 2021 Nov; 16(22):3439-3450. PubMed ID: 34355531
[TBL] [Abstract][Full Text] [Related]
24. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of kynurenine production by N,O-substituted hydroxylamine derivatives.
Iijima M; Otsuka Y; Ohba SI; Momose I
Bioorg Med Chem Lett; 2024 Jul; 106():129731. PubMed ID: 38621594
[TBL] [Abstract][Full Text] [Related]
26. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
[TBL] [Abstract][Full Text] [Related]
28. Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design.
Yeh TK; Song JS; Chang PW; Yu JC; Chang CH; Liao FY; Tien YW; Kuppusamy R; Li AS; Chen CH; Chen CW; Lin LM; Chang HH; Huang CH; Yao JY; Wu MH; Peng YH; Hsueh CC; Hsiao WC; Chen PH; Lin CY; Hsieh SH; Shih C; Hung MS; Wu SY; Kuo CC; Ueng SH
Eur J Med Chem; 2022 Feb; 229():114043. PubMed ID: 34929581
[TBL] [Abstract][Full Text] [Related]
29. Cell-Based Identification of New IDO1 Modulator Chemotypes.
Hennes E; Lampe P; Dötsch L; Bruning N; Pulvermacher LM; Sievers S; Ziegler S; Waldmann H
Angew Chem Int Ed Engl; 2021 Apr; 60(18):9869-9874. PubMed ID: 33565680
[TBL] [Abstract][Full Text] [Related]
30. Fragment-based approach to identify IDO1 inhibitor building blocks.
Coletti A; Camponeschi F; Albini E; Greco FA; Maione V; Custodi C; Ianni F; Grohmann U; Orabona C; Cantini F; Macchiarulo A
Eur J Med Chem; 2017 Dec; 141():169-177. PubMed ID: 29031064
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
Cui G; Lai F; Wang X; Chen X; Xu B
Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z
Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078
[TBL] [Abstract][Full Text] [Related]
33. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.
Ortiz-Meoz RF; Wang L; Matico R; Rutkowska-Klute A; De la Rosa M; Bedard S; Midgett R; Strohmer K; Thomson D; Zhang C; Mebrahtu M; Guss J; Totoritis R; Consler T; Campobasso N; Taylor D; Lewis T; Weaver K; Muelbaier M; Seal J; Dunham R; Kazmierski W; Favre D; Bergamini G; Shewchuk L; Rendina A; Zhang G
Chembiochem; 2021 Feb; 22(3):516-522. PubMed ID: 32974990
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form.
Pradhan N; Akhtar N; Nath B; Peña-García J; Gupta A; Pérez-Sánchez H; Kumar S; Manna D
Chem Commun (Camb); 2021 Jan; 57(3):395-398. PubMed ID: 33326535
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors by virtual screening.
Zhou Y; Peng J; Li P; Du H; Li Y; Li Y; Zhang L; Sun W; Liu X; Zuo Z
Comput Biol Chem; 2019 Feb; 78():306-316. PubMed ID: 30616156
[TBL] [Abstract][Full Text] [Related]
37. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
[TBL] [Abstract][Full Text] [Related]
39. Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Röhrig UF; Majjigapu SR; Reynaud A; Pojer F; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Michielin O; Zoete V
J Med Chem; 2021 Feb; 64(4):2205-2227. PubMed ID: 33557523
[TBL] [Abstract][Full Text] [Related]
40. Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Williams DK; Markwalder JA; Balog AJ; Chen B; Chen L; Donnell J; Haque L; Hart AC; Mandal SK; Nation A; Shan W; Vite GD; Covello K; Hunt JT; Jure-Kunkel MN; Seitz SP
Bioorg Med Chem Lett; 2018 Feb; 28(4):732-736. PubMed ID: 29398543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
